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Notch regulates multiple stages of T cell devel-
opment (1, 2). Canonical Notch signaling in-
volves release of the intracellular (i.c.) Notch 
(ICN) domain into the cytoplasm and ICN 
migration to the nucleus. ICN forms a com-
plex with the transcription factor CSL/RBP-J, 
creating a binding interface that recruits tran-
scriptional coactivators of the Mastermind-like 
(MAML) family (3). Disruption of Notch1 sig-
naling leads to B cell accumulation in the thy-
mus and a block in T cell development (4). 
Notch is required to generate the earliest T lin-
eage progenitors in the thymus (5, 6). Subse-
quent diff   erentiation depends on continuous 
Notch signaling (7–11). In particular, Notch is 
important for developmental progression from 
the CD4−CD8− double-negative (DN) to the 
CD4+CD8+ double-positive (DP) stage at the 
β-selection checkpoint.
Several studies have identifi   ed a role for 
Notch during β-selection, although they have 
provided confl   icting information as to the 
mechanism and importance of this eff  ect. In 
vivo, Lck-Cre (LC)–mediated inactivation of 
Notch1 or CSL/RBP-J at the CD25+CD44− 
DN3 stage decreased but did not abolish the 
generation of DP cells (7, 9). This was associ-
ated with accumulation of DN3 cells that were 
abnormally bright for CD25 and CD25−CD44− 
DN4-like cells with reduced expression of i.c. 
TCRβ. DN3 and DN4 cells in Notch1-defi  -
cient mice had impaired V-DJβ rearrangement 
(7). In addition, Notch could induce Ptcra tran-
scripts (encoding pre-TCRα) (12). These fi  nd-
ings suggested that Notch might act at the 
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Genetic inactivation of Notch signaling in CD4−CD8− double-negative (DN) thymocytes 
was previously shown to impair T cell receptor (TCR) gene rearrangement and to cause a 
partial block in CD4+CD8+ double-positive (DP) thymocyte development in mice. In con-
trast, in vitro cultures suggested that Notch was absolutely required for the generation of 
DP thymocytes independent of pre-TCR expression and activity. To resolve the respective 
role of Notch and the pre-TCR, we inhibited Notch-mediated transcriptional activation 
in vivo with a green fl  uorescent protein–tagged dominant-negative Mastermind-like 1 
(DNMAML) that allowed us to track single cells incapable of Notch signaling. DNMAML 
expression in DN cells led to decreased production of DP thymocytes but only to a modest 
decrease in intracellular TCR𝗃 expression. DNMAML attenuated the pre-TCR–associated 
increase in cell size and CD27 expression. TCR𝗃 or TCR𝗂𝗃 transgenes failed to rescue 
DNMAML-related defects. Intrathymic injections of DNMAML− or DNMAML+ DN thymo-
cytes revealed a complete DN/DP transition block, with production of DNMAML+ DP thy-
mocytes only from cells undergoing late Notch inactivation. These fi  ndings indicate that 
the Notch requirement during the 𝗃-selection checkpoint in vivo is absolute and indepen-
dent of the pre-TCR, and it depends on transcriptional activation by Notch via the CSL/
RBP-J–MAML complex.
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β-selection checkpoint by regulating pre-TCR expression. 
In contrast, in vitro studies have suggested that the require-
ment for Notch was independent of the pre-TCR (10). In-
stead, Notch was shown to infl  uence cellular metabolism and 
survival through a molecular pathway involving activated 
Akt (11).
The basis for the discrepancy between the in vivo and 
in vitro data is unclear. One possibility is that the requirement 
for the metabolic eff  ects of Notch is less stringent in vivo 
than in vitro. This could create a situation in which eff  ects 
of Notch on pre-TCR expression are limiting only in vivo. 
Alternatively, pre-TCR–independent eff  ects of Notch could 
be critical in vivo, and the apparent leakiness of the DN-DP 
transition block could be related to the precise timing of 
Notch inactivation.
To address these questions, we generated mice expressing 
a conditional allele of the pan-Notch inhibitor dominant-
negative MAML1 (DNMAMLf/+) (13, 14). The DNMAML 
allele is linked to a GFP sequence, providing the opportunity 
to track single Notch-deprived cells. We bred DNMAMLf/+ 
mice with LC transgenic (tg) mice. Our results demonstrate 
an absolute requirement for a CSL/RBP-J–dependent, pre-
TCR–independent eff  ect of Notch at the β-selection check-
point in vivo.
RESULTS AND DISCUSSION
Impaired 𝗂𝗃 but not 𝗄𝗅 T cell development 
in LC x DNMAMLf/+ (LCD) mice
To inhibit signaling from all Notch receptors (Notch1–4), 
we generated DNMAMLf/+ mice (14) (Fig. 1 A). These mice 
harbor a cassette encoding the GFP-tagged Notch inhibitor 
DNMAML downstream of a fl  oxed sequence that prevents 
transcription of DNMAML. Cre recombinase results in DN-
MAML expression from the ubiquitously active ROSA26 
promoter. Notch-deprived cells can be tracked through GFP 
detection. DNMAMLf/+ mice were crossed to LC tg mice to 
generate LCD mice and compared with control LC litter-
mates. GFP expression was detected in a small percentage of 
CD44+CD25+ DN2 cells (Fig. 1 B). In subsequent stages, 
DNMAML was induced in >50% of CD44−CD25+ DN3 
cells and >95% of CD44−CD25− DN4, TCRβ−CD8+ 
  immature single-positive and CD4+CD8+ DP cells.
Figure 1.  Characterization of LCD mice. (A) Structure of the ROSA26 
DNMAMLf/+ locus. Triangles represent loxP sites. SA, splice acceptor; tpA, 
trimer of SV40 polyadenylation sequence; bpA, bovine growth hormone 
polyadenylation sequence. (B) GFP expression in LCD thymocyte subsets. 
(C) Flow cytometric analysis of LC and LCD thymi. Numbers in B and C 
represent the percentage of cells in the indicated areas. (D) Absolute 
number of thymocyte subsets in LC and LCD mice. Numeric data represent 
means ± SEM (n = 8). *, P < 0.01 according to the Student’s t test. 
γδ T, all CD3+ TCRγ+ T cells (including CD8α+).JEM VOL. 203, October 2, 2006  2241
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LCD thymi had impaired αβ T cell development, as 
shown by a decreased percentage of DP and an increased 
percentage of DN cells (Fig. 1 C), translating into a four to 
fi  vefold decrease in thymic cellularity (Fig. 1 D). The abso-
lute number of DN cells was preserved, whereas numbers 
of immature single-positive, DP, CD4+ single positive (SP) 
and mature CD8+ SP cells were decreased, which was con-
sistent with a block at the DN-DP transition. Among CD3+ 
thymocytes, the percentage of TCRγ+ cells was increased 
in LCD mice (Fig. 1 C), an eff  ect secondary to decreased 
TCRβ+ cells because the absolute number of TCRγ+ cells 
was maintained (Fig. 1 D). This was observed despite expres-
sion of DNMAML in  80% of LCD γδ thymocytes (Fig. 1 B). 
Regarding αβ T cell development, our observations in LCD 
mice were consistent with fi   ndings reported after LC-
  mediated inactivation of Notch1 or CSL/RBP-J (7, 9). In 
contrast, the preservation of γδ thymocytes in LCD mice was 
similar to LC x Notch1f/f mice (7) but diff  ered from the in-
crease in absolute γδ cell numbers in LC x CSL/RBP-Jf/f 
mice (9). This cannot be explained by Notch2–4 activity af-
ter Notch1 deletion because signaling from all four Notch re-
ceptors is inhibited both by DNMAML (14) and the absence 
of CSL/RBP-J. A potential explanation is that Notch-inde-
pendent CSL/RBP-J–mediated transcriptional repression 
plays a role during γδ development. This repressor function 
would be lost in the absence of CSL/RBP-J but is unaff  ected 
by DNMAML. Alternatively, subtle diff  erences in genetic 
background or timing of Notch inactivation may account for 
the discrepant results.
Characterization of LCD CD4−CD8− DN thymocytes
We studied the phenotype of Lin− DN thymocytes in LC and 
LCD mice (Fig. 2), using GFP to better defi  ne the eff  ects of 
Notch deprivation. The proportions of DN2, DN3, and DN4 
cells were similar in LC and LCD thymi (Fig. 2 A). LCD DN3 
cells expressed higher levels of CD25 than LC DN3 cells (Fig. 
2 A). Although the diff  erence was modest, it was statistically 
signifi  cant (Fig. S1, available at http://www.jem.org/cgi/ 
content/full/jem.20061020/DC1). In addition to DN3 cells, 
abnormal CD25hi DN2 cells were also present in LCD mice. 
These fi  ndings were reminiscent of the CD25hi DN2-DN3 
population observed after LC-mediated inactivation of Notch1 
or CSL/RBP-J (7, 9). This population was hypothesized to 
represent Notch-deprived DN2-DN3 cells that failed to un-
dergo β-selection, as in mice lacking pre-TCR components 
(7). However, all CD25hi DN2-DN3 cells in LCD mice were 
GFP−, whereas GFP+ DN3 cells expressed lower levels of 
CD25 than the GFP− DN3 cohort (Fig. 2 A). These fi  ndings 
indicated that CD25hi DN2-DN3 cells emerged in LCD mice 
not as a direct consequence of Notch deprivation but because 
of a non–cell autonomous eff  ect; e.g., an abnormality in intra-
thymic niches occupied by DNMAML+ DN cells.
Figure 2.  Lin− thymocyte subsets in LCD mice. (A) Flow cytometric 
analysis of LC/LCD Lin− thymocytes. Boxed regions identify CD44+CD25+ 
DN2, CD44−CD25+ DN3, and CD44−CD25− DN4 cells. CD25 expression in 
DN2-DN3 cells was higher in LCD than in LC mice (dashed line). Numbers 
represent the percentage of cells in the indicated areas. (B) Expression of 
i.c. TCRβ (LC, n = 11; LCD n = 12) and TCRγ (LC, n = 8; LCD, n = 9) in 
DN3 and DN4 cells from LC and LCD mice. (C) Decreased DN3b population 
in LCD versus LC DN3 cells. CD27hiFSChi or CD27hiCD44lo DN3 cells have 
been defi  ned as DN3b thymocytes (reference 15). Plots are gated on total 
(GFP− and GFP+) Lin− DN3 cells. (D) Cell cycle analysis of LC/LCD Lin− DN3 
and DN4 cells (n = 7 and 8, respectively). Numbers in C and D represent 
the percentage of cells in the indicated areas. (E) BrdU incorporation after 
a 3-h labeling (n = 6 and 7, respectively). Numeric data represent means ± 
SEM. *, P < 0.05; or **, P < 0.01 according to the Student’s t test.2242  NOTCH AND β-SELECTION IN VIVO | Maillard et al.
We next assessed LC/LCD DN3 and DN4 cells for i.c. 
TCRβ and TCRγ (Fig. 2 B and Fig. S2, available at http://
www.jem.org/cgi/content/full/jem.20061020/DC1). The 
percentage of i.c. TCRβ+ DN3 and DN4 cells showed a 
modest, though statistically signifi  cant, decrease in LCD as 
compared with LC mice. The percentage of i.c. TCRγ+ 
thymocytes was not signifi  cantly diff  erent.
We then examined LC/LCD DN3 cells for phenotypic 
changes associated with β-selection (Fig. 2, C–E). DN3 cells 
exposed to pre-TCR signals exhibit active cell cycling, in-
creased cell size, and CD27 up-regulation (DN3b popula-
tion) (15). FSChiCD27hi or CD44loCD27hi DN3b cells were 
reduced in LCD as compared with LC thymi (Fig. 2 C). 
When assessed for DNA content, a smaller proportion of 
DN3 cells were in the S-G2M phases of the cell cycle (Fig. 
2 D) and fewer cells incorporated BrdU in LCD as com-
pared with LC DN3 cells (Fig. 2 E). In contrast, no signifi  -
cant proliferation defect was detected in DN4 cells. The 
proportion of i.c. TCRβ+ cells was reduced among BrdU+ 
LCD as compared with LC DN3 cells (LC, 68 ± 3% vs. 
LCD, 43 ± 4%; mean ± SEM; P < 0.01), a fi  nding that was 
consistent with reports of impaired proliferation, predomi-
nantly in αβ lineage cells in vitro (16, 17). Collectively, 
these fi   ndings indicate that Notch-deprived DN3 cells, 
  although detected phenotypically as CD25lo cells at the 
DN3-DN4 transition, failed to undergo the typical changes 
associated with β-selection. We recently reported that Notch 
directly up-regulates c-myc transcription in primary DN3 
cells and T cell leukemia cell lines, suggesting that abroga-
tion of the Notch–c-myc axis contributes to the β-selection 
defects in LCD mice (18).
In vitro studies using Rag-defi  cient DN3 cells on OP9-
DL1 stroma found that Notch signaling had important roles 
in cell metabolism and survival. In contrast, we did not detect 
consistent abnormalities in Annexin V staining and cellular 
bioenergetics, as measured by tetramethylrhodamine ethyl 
ester labeling in LCD thymi (unpublished data). This does 
not rule out Notch-related changes in these parameters be-
cause compromised/dying thymocytes are rapidly eliminated 
and have been notoriously diffi   cult to detect in vivo (19).
The in vivo DNMAML-related defects were reminis-
cent of in vitro fi  ndings using OP9 cells in which the main 
consequences of Notch deprivation were growth arrest, de-
creased cell size, and eventual cell death (10, 11). To better 
understand changes induced by the loss of Notch signaling, 
we assessed cell size and CD25 expression in cultures of 
LC DN3 or LCD GFP+ DN3 thymocytes with OP9-DL1 
cells (Fig. 3 A). After 24 h, LCD GFP+ DN3 cells exhibited 
decreased cell size and CD25 expression when compared 
with LC DN3 cells. Therefore, these changes resulted from 
a transcriptional eff  ect of Notch signaling mediated by the 
ICN-CSL-RBP-J–MAML complex. The rapid modulation 
of CD25 expression suggested that Cd25 (Il2ra) is a direct 
transcriptional Notch target in thymocytes (20). A chroma-
tin precipitation (ChIP) assay showed that Notch1 associated 
with two conserved CSL/RBP-J binding sites in the Il2ra 
locus; one is located immediately upstream of the transcrip-
tion start site and the other in intron 3 (Fig. 3 B) These 
fi  ndings confi  rm that Il2ra is a Notch transcriptional target in 
developing thymocytes.
Collectively, these observations suggest a scenario in 
which Notch-deprived DN3 cells down-regulate CD25 and 
fail to proliferate. Thus, some CD44−CD25lo DN3-DN4 
thymocytes in LCD mice might represent Notch-deprived 
DN3 cells that have aberrantly down-regulated CD25. How-
ever, these cells did not accumulate to a large extent in LCD 
mice, as shown by the nearly normal frequency of i.c. TCRβ+ 
cells among LCD DN4 thymocytes (Fig. 2 B). The minimal 
accumulation of Notch-deprived DN cells in LCD mice 
might be related to their growth arrest (Fig. 2 D) and/or 
rapid elimination by apoptosis, which was consistent with 
in vitro work showing poor survival of cells lacking both Notch 
and pre-TCR signaling (16). In comparison to LCD mice, 
the accumulation of aberrant CD25lo DN3-DN4 cells ap-
peared more prominent in LC x Notch1f/f and, to a lesser ex-
tent, in LC x CSL/RBP-Jf/f mice, even if overall impairment 
of T cell development was similar (7, 9). We hypothesize that 
residual Notch signaling through Notch2–4 receptors in LC 
x Notch1f/f mice, or preformed CSL/RBP-J protein in LC x 
CSL/RBP-Jf/f mice, contributed to enhanced accumulation 
Figure 3.  Loss of canonical Notch signaling results in decreased 
cell size and CD25 expression. (A) Sorted LC or LCD GFP+ DN3 thymo-
cytes were cultured with OP9-DL1 cells expressing the Notch ligand 
Delta-like 1. Flow cytometric analysis was performed after 24 h. (B) Struc-
ture of the Il2ra(Cd25) locus showing three conserved putative CSL/RBP-J 
binding sites. (C) ChIP assay from purifi  ed DN3 cells using anti-Notch1 
(αNotch1), antiacetylated histone 4 (αAcH4), or control rabbit antibodies, 
followed by quantitative PCR. Input DNA (aliquot of preimmunoprecipita-
tion–sheared chromatin) was used for normalization. Numeric data 
 represent  means  ± SEM.JEM VOL. 203, October 2, 2006  2243
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of aberrant DN3-DN4 cells without allowing normal pro-
gression through β-selection.
No rescue of Notch-deprived DN cells by Tcrb 
or Tcra/b transgenes
As in the absence of Notch1 and CSL/RBP-J (7, 9), i.c. 
TCRβ expression was decreased in LCD DN3 cells (Fig. 2 B). 
To assess if this was functionally relevant in vivo, we crossed 
LCD mice to Tcrb tg mice (Fig. 4, A and B). DNMAML 
did not aff  ect transgene expression (Fig. S3, available at
http://www.jem.org/cgi/content/full/jem.20061020/DC1). 
The Tcrb transgene failed to restore cellularity of LCD thymi 
back to normal numbers (Fig. 4 A), despite a twofold   increase 
in LCD/Tcrb tg mice. The percentage of LCD DP cells 
was decreased with and without the transgene (Fig. 4 B), 
  although the decrease was slightly less pronounced with Tcrb. 
However, we consistently observed a higher percentage of 
GFP− cells among DP thymocytes of LCD/Tcrb tg than in 
non-tg LCD mice. This suggested that the transgene accel-
erated the transition through DN2-DN4 stages of develop-
ment, allowing more DP cells to arise without being exposed 
to DNMAML. Together, these results indicated that a Tcrb 
transgene did not rescue Notch inactivation at the β-selection 
checkpoint in vivo.
In addition to its eff  ect on TCRβ, Notch might regulate 
pTα expression (12). To assess if this played a limiting role 
in vivo, we crossed LCD mice to TcrAND tg mice (Fig. 
4, C and D). These mice express Tcra/b transgenes that can 
substitute for pre-TCR function (21), though with reduced 
effi   ciency (22). Expression of the Tcra/b transgenes did not 
restore thymic cellularity (Fig. 4 C). Accordingly, the per-
centage of DP cells was reduced in LCD/TcrAND as com-
pared with TcrAND mice (Fig. 4 D). Similar results were 
observed with DO11.10 tg mice (unpublished data).
These results show that Notch deprivation in vivo cannot 
be rescued by restoring pre-TCR function. Instead, they 
suggest that Notch and the pre-TCR act in parallel pathways. 
An important future task will be to characterize the interac-
tions between Notch, pre-TCR signals, and other partners 
that are active during β-selection, such as E proteins. Of 
note, recent work indicates that Notch and E proteins coop-
erate during T lineage commitment (23).
Intrathymic injections reveal an absolute DN to DP 
differentiation block in the absence of Notch 
signaling in vivo
In vitro experiments suggested an absolute requirement for 
Notch at the DN-DP transition (10, 11). However, the gen-
eration of LCD DP cells was reduced but not abolished in 
vivo. This could be explained by a less stringent requirement 
for Notch signaling in vivo or by the precise kinetics of LC-
mediated excision. To diff  erentiate between these possibili-
ties, we purifi  ed GFP− and GFP+ DN3 cells from LCD mice 
and performed intrathymic injections (Fig. 5). Control LC 
DN3 cells gave rise to donor-derived DP/SP T cells 10 d 
  after injection (Fig. 5 A, top). In contrast, Notch-deprived 
GFP+ LCD DN3 cells gave rise to no or barely detectable 
progeny (Fig. 5 A, middle). There was at least a 3-log reduc-
tion in donor-derived cells in the absence of Notch signaling 
(Fig. 5 B). When GFP− LCD DN3 cells were injected, sig-
nifi  cant numbers of donor-derived DP/SP cells were ob-
served at day 10 (Fig. 5 A, bottom), and >50% of these cells 
were GFP+ as a result of DNMAML induction in vivo be-
tween injection and analysis. These results indicate that the 
requirement for Notch during β-selection is as stringent in 
vivo as in vitro. Furthermore, the apparently partial diff  eren-
tiation block observed in vivo results from late Notch inacti-
vation in a fraction of DN3-DN4 cells.
In conclusion, our observations bring new insights into 
the role of Notch at the β-selection checkpoint in vivo. By 
tracking Notch-deprived cells, we demonstrated an absolute 
requirement for Notch signaling during β-selection that was 
not rescued by restoring pre-TCR function. Our results are 
consistent with a predominant and limiting eff  ect of Notch 
on proliferation and cell survival, although we cannot rule 
out additional eff  ects on diff  erentiation. Because the eff  ect 
was observed on interference with the Notch transcriptional 
activation complex, future work to identify relevant downstream 
Figure 4.  Tcrb and Tcra/b transgenes do not rescue DN to DP 
  differentiation in the absence of Notch signaling in vivo. LC and LCD 
were bred to Tcrb or Tcra/b (TcrAND) tg mice. F1 progeny were compared 
with parental tg mice. (A) Total thymocyte numbers in Tcrb tg (n = 7), 
Tcrb tg x LCD (n = 7), and LCD mice (n = 8). Numeric data represent 
means ± SEM. (B) CD4/CD8 expression in Tcrb tg, Tcrb tg x LCD, and LCD 
thymi (top) and GFP expression in DP cells (bottom). Numbers represent 
the percentage of cells in the indicated areas. (C) Total thymocyte num-
bers in TcrAND tg and TcrAND tg x LCD mice (n = 5). Numeric data rep-
resent means ± SEM. (D) CD4/CD8 expression in TcrAND tg and TcrAND 
tg x LCD thymi. Numbers represent the percentage of cells in the 
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mediators of Notch will have to focus on transcriptional 
  targets of Notch signaling.
MATERIALS AND METHODS
Mice. DNMAMLf/+ mice were generated as previously described (14). The 
DNMAML-GFP construct encodes amino acids 13–74 of MAML1 fused to 
GFP (13, 14). DNMAMLf/+ mice were crossed to LC tg mice (Taconic). 
LCD mice were compared with LC littermates. B6.CD45.1 and Tcrb tg mice 
expressing a TCRβ chain from the DO11.10 hybridoma were obtained 
from Taconic. Tg(TcrAND) and Tg(DO11.10) Tcra/Tcrb tg mice were pur-
chased from the Jackson Laboratory. Experimental protocols were approved 
by the University of Pennsylvania Offi   ce of Regulatory Aff  airs.
Antibodies. The following antibodies were from obtained from BD Biosci-
ences or eBioscience: PE anti-CD25 (PC61), CD27 (LG.7F9), TCRβ (H57-
597), TCRγ (GL3), CD4 (RM4-5), and CD3 (145-2C11); APC anti-CD4, 
TCRβ, CD44 (IM7), and BrdU; biotinylated anti-CD45.2 (104), CD8 
(53-6.7), TCRβ, TCRγ, CD4 (GK1.5), CD3, NK1.1 (PK136), B220 (RA3-
6B2), CD19 (1D3), CD11b (M1/70), Gr1 (RB6-8C5), and CD11c (HL3); 
APC-Cy7 anti-CD25; and PE-Cy5.5 anti-CD44 and PE-Cy7 anti-CD45.1 
(A20). Biotinylated antibodies were revealed with streptavidin-PerCP (BD 
Biosciences), Pacifi  c Blue (Invitrogen), or PE–Texas red (Caltag). Lineage+ 
cells were defi  ned with anti-CD8, TCRβ, TCRγ, NK1.1, CD3, B220, 
CD19, CD11b, Gr1, and CD11c.
Flow cytometry and cell sorting. Cells were stained in PBS/2% FCS. i.c. 
staining was performed with fi  xation/permeabilization or BrdU labeling kits 
(Becton Dickinson). 0.5 mg BrdU was administered i.p. 3 and 1 h before 
death. Cells were sorted on a FACS DiVa (Beckton Dickinson) or a MoFlo 
(DakoCytomation). Analysis was performed on a FACS Calibur or LSR II 
(Becton Dickinson). DAPI was used to exclude dead cells or assess DNA con-
tent in fi  xed cells. Files were analyzed with software (FlowJo; Tree Star, Inc.).
Intrathymic injections. 1–2 × 105 sorted DN3 cells were injected intra-
thymically in anesthetized B6.CD45.1 recipients given 500 rad 2–6 h 
  before injection.
OP9 cultures. OP9-DL1 cells were provided by J.C. Zuniga-Pfl  ucker 
(University of Toronto, Toronto, Canada) and used as previously described (24). 
Progenitors were seeded into 24-well plates containing a stromal monolayer 
with 1 ng/ml mIL-7 (PeproTech).
ChIP. ChIP was performed from Rag-2−/− DN3 cells using Notch1 TAD 
domain–specifi  c antiserum (25), anti-acetylated histone 4 (Upstate Biotech-
nology), or rabbit IgG (Santa Cruz Biotechnology, Inc.), as previously de-
scribed (18). Quantitative PCR was performed with SYBR green (Applied 
Biosystems) and the following Il2ra-specifi  c primers: 25K, 5′ C  A  G  T  C  A  T  T-
G  G  T  T  G  G  C  C  A  C  T  C  T   3 ′ and 5′ G  G  A  C  C  T  C  C  A  T  G  C  A  G  A  C  A  T  C  A   3 ′; 
promoter, 5′ T G  T  T  G  A  G  T  C  T  T  C  T  G  G  G  G  G  A  G  A  A   3′ and 5′ C T  A  G  G  A  G-
G  T  G  T  G  G  G  C  A  G  T  G  T  T  T   3′; and intron 3, 5′ T G  C  A  G  C  A  T  G  G  G  T  C  A  A  A-
T  G  A  A   3′ and 5′ A  G  G  T  C  T  C  C  C  C  A  G  G  A  A  A  A  G  T  C  A  C   5′.
Online supplemental material. Fig. S1 depicts CD25 median fl  uores-
cence intensity in Lin− CD44 DN3/DN4 LCD as compared with LC thy-
mocytes. Fig. S2 shows expression of i.c. TCRβ and i.c. TCRγ in Lin− 
DN3-DN4 LC and LCD thymocytes (a representative example is presented). 
Fig. S3 shows expression of i.c. TCRβ in the presence or absence of a Tcrb 
transgene in LC and LCD DN thymocyte subsets.
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